Regeneron Will Move Two Factor XI Agents Into Phase III

 
• By Joseph Haas
  
Regeneron reports positive Phase II data for two factor XI anticoagulants • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Therapy Areas